Skip to main content
. 2011 Jul 1;5(4):928–935. doi: 10.1177/193229681100500416

Table 1.

Clinical Measurements Conducted at Gateway for Assessment of Impact of the 8-Week Intervention

Clinic measurements n Mean week 0 ±Standard deviation Mean week 8 ±Standard deviation t-test Mean difference ± standard deviation 95% confidence interval, lower 95% confidence interval, upper
Waist circumference (cm) 24 111.54 81.04 107.68 135.47 0.002a -3.86 ± 5.43 -6.16 -1.57

BMI kg/m2 24 33.14 19.01 32.67 18.76 0.03a -0.465 ± 0.987 -0.88 -0.05

Glucose (mmol/liter) 24 6.03 5.74 5.52 1.22 0.221 -0.508 ± 1.981 -1.345 0.328

HbA1c (%) 16 0.060 0.000 0.059 0.000 0.182 -0.001 ± 0.003 -0.002 0.000

SBP (mm Hg) 24 141 95 139 351 0.475 -2.125 ± 14.342 -8.181 3.931

DBP (mm Hg) 24 85 71 80 80 0.046a -4.458 ± 10.37 -8.836 -0.081

Total cholesterol (mmol/liter) 24 5.48 1.61 5.19 1.23 0.009a -0.295 ± 0.508 -0.510 -0.080

LDL cholesterol (mmol/liter) 24 3.14 2.37 3.13 1.15 0.983 -0.04 ± 0.189 -0.396 0.388

HDL cholesterol (mmol/liter) 24 1.34 0.11 1.35 0.16 0.655 0.013 ± 0.029 -0.048 0.074

Triglycerides (mmol/liter) 24 1.80 1.76 1.53 0.55 0.153 -0.273 ± 0.905 -0.655 0.109

C-reactive protein (mmol/liter) 24 3.98 3.49 0.284 -0.493 ± 2.198 -1.420 0.435

Training HR (bpm) 24 118 63 124 85 <0.000a 5.958 ± 6.182 3.348 8.569

VO2max (ml/kg/min) 24 29.54 31.39 34.68 49.24 <0.000a 5.139 ± 4.911 7.213 3.066

Self-monitoring measurements

SBP (mm Hg) 24 136 15 133 18 0.165 3.875 ± 13.224 -1.709 9.459

DBP (mm Hg) 24 88 10 84 9 0.001a 4.375 ± 5.640 1.993 6.757

HR (bpm) 24 70 12 67 13 0.008a 2.91 ± 6.8 0.0046 5.82

Glucose am (mmol/liter) 24 6.71 2.40 6.30 1.20 0.264 1.731 ± 0.353 -0.327 1.135

Glucose pm (mmol/liter) 24 7.48 2.80 6.93 1.54 0.213 0.550 ± 2.105 -0.339 1.439

Pedometer (steps/day) 24 5671 1989 6757 2454 0.003a -1085 ± 1613 -1767 -404

Weight (kg) 21 92.74 13.97 92.12 13.77 0.312 0.620 ± 2.942 -0.622 1.863
a

Significant statistical difference for values from week 0 to week 8.